4Auperin A, Le Pechoux C, Rolland E, et al. Meta - analysis of concomitant versus sequential radiochemotherapy in locally advanced non - small - cell lung cancer [J]. Clin Oncol, 2010, 28 (13): 2181- 90.
5Curran W, Scott C, Langer C, et al. Long - term benefit is observed in a phase Ill comparison of sequential vs concurrent chemo - radiation for patients with unresected stage III NSCLC: RTOG94 - 10 [J]. Am Soc Clin Oncol, 2003, 22: 633.
6Stephens RJ, Fairlamb D, Gower N, et al. The big lung trial determing the value of eisplatin - based chemotherapy for all patients with non - small cell lung cancer preliminary results in the supportive care setting [J]. Proc AM SOC elin Oneol, 2002, 21: 1161.
7Langer F, Helsberg K, Schutte WH, et al. Gemcitabine in the first line therapy of advanced and metastatic non - small cell lung carcinoma (NSCLC) : review of the results of phase Ⅲ studies [J]. Onkologie, 2005, 28 (1): 1-28.
8Moscetti L, Nelli F, Padalino D, et al. Gemcitabine and cisplatin in the treatment of elderly patients with advanced non - small cell lung cancer: impact of comorbidities on safety and efficacy outcome [J]. J Cemother, 2005, 17 (6): 685-692.
9Monnet I, Brienza S, Hugret F, et al. Phase Ⅱ study of oxaliplatin in poor- prognosis non - small cell lung cancer (NSCLC). ATTIT. Association pour le treatement des tumeurs intra thoraciques [J]. EurJ Cancer, 1998, 34 (7): 1124-1127.
10Kakolyfis S, Ziras N, Vamvakas L, et al. Gemeitabine plus oxaliplatin combination (gemox regimen) in pretreated patients with advanced non - small cell lung cancer (NSCLC) : a multicenter phase Ⅱ study [J]. Lung Cancer, 2006, 54 (3): 347-352.
2Funai K, Takamochi K, Itaya T,et al. Feasibility study of adju-vant chemotherapy with gemcitabine and split-dose cisplatin forcompletely resected non-small-cell lung cancer[ J]. Lung Cancer,2010,63(5):223-230.
3Le Chevalier T. Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going. [ J ]. Ann Oncol, 2010,21 Suppl7:viil96-198.
4Tibaldi C, Mazzoni E, Arcabasso G, et al. Cisplatin plus gemcit-abine as adjuvant chemotherapy for radically resected non-small-cell lung cancer: a pilot study [ J ]. Clin Lung Cancer, 2009,10(1) :53-57.
5Funai K, Takamochi K, Itaya T, et al. Feasibility study of adju-vant chemotherapy with gemcitabine and split-dose cisplatin forcompletely resected non-small-cell lung cancer[ J]. Lung Cancer,2010,68(1) :78-83.
7Usarai N, Yokoi K, Hasegawa Y, et al. Phase H study of carbo-platin and gemcitabine as adjuvant chemotherapy in patients withcompletely resected non-small cell lung cancer: a report from theCentral Japan Lung Study Group, CjLSG 0503 trial[ J]. Int J ClinOncol, 2010,15(6) :583-587.
